<DOC>
	<DOCNO>NCT01049347</DOCNO>
	<brief_summary>Activation hypothalamus-pituitary-adrenal system monitor use saliva cortisol sample antidepressant treatment amitriptyline paroxetine moderately severely depressed patient . Additionally , serum plasma sample 5-week study period order study endocrine metabolic parameter .</brief_summary>
	<brief_title>Amitriptyline Paroxetine Treatment Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Amitriptyline</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Amitriptyline , perphenazine drug combination</mesh_term>
	<criteria>age : 18 depression accord DSMIV bipolar disorder substance dependency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>depression</keyword>
</DOC>